Harnessing Oncolytic Virus-mediated Antitumor Immunity

Harnessing Oncolytic Virus-mediated Antitumor Immunity

Bibliographic Details
Main Author:	Volker eSchirrmacher
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-11-01
Series:	Frontiers in Oncology
Subjects:	Oncolytic Virotherapy oncolytic virus anti-tumor activity Anti-Viral Response tumor-associated antigen immunotherapeutic approaches
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00337/full

Similar Items

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01)

Exploiting tumor epigenetics to improve oncolytic virotherapy
by: Nicole E. Forbes, et al.
Published: (2013-09-01)

Tumor-Homing of Mesenchymal Stem Cells Infected with Oncolytic Virus in a Canine Patient
by: Pablo Delgado-Bonet, et al.
Published: (2022-06-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumors
by: Isabela Granha, et al.
Published: (2024-06-01)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
by: Masmudur M. Rahman, et al.
Published: (2021-10-01)

Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
by: Simona Ruxandra Volovat, et al.
Published: (2024-01-01)

Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
by: Mengyuan Li, et al.
Published: (2023-09-01)

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity
by: Zhongbing Qi, et al.
Published: (2023-04-01)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022-11-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma
by: Kelly M. Makielski, et al.
Published: (2023-12-01)

Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01)

Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
by: Sauson Soldozy, et al.
Published: (2023-06-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01)

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
by: Licheng Zhu, et al.
Published: (2023-04-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
by: Masakazu Hamada, et al.
Published: (2020-09-01)

Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option
by: Jiasen He, et al.
Published: (2023-01-01)

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
by: Palaniyandi Muthukutty, et al.
Published: (2023-07-01)

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors
by: Jérémy Béguin, et al.
Published: (2023-09-01)

Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
by: Nadia Ghasemi Darestani, et al.
Published: (2023-02-01)

Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
by: Xianwang Wang, et al.
Published: (2023-07-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
by: Zengbin Li, et al.
Published: (2020-05-01)

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01)

Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
by: Sarah E. Blitz, et al.
Published: (2022-02-01)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
by: Eleni Kalafati, et al.
Published: (2023-07-01)

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
by: Jessica A. Minott, et al.
Published: (2022-09-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
by: Elizabeth Robilotti, et al.
Published: (2023-09-01)

Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells
by: Shinya Tada, et al.
Published: (2018-01-01)

Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy
by: Xinjun Liu, et al.
Published: (2022-09-01)

Enhancing oncolytic virotherapy of glioblastoma by targeting innate immune ligands with a bispecific T cell engager
by: Baugh, R
Published: (2022)

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
by: Yi-Ying Wu, et al.
Published: (2023-03-01)

Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
by: Henglong Hu, et al.
Published: (2022-11-01)